Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Probiotics | Research article

The effects of curcumin and Lactobacillus acidophilus on certain hormones and insulin resistance in rats with metabolic syndrome

Authors: Fatma Semina Kapar, Gülay Ciftci

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Purpose

In this study, we tried to investigate the effects of curcumin and Lactobacillus acidophilus probiotics, given individually and in combination, to insulin, adipokines and nitric oxide changes and insulin resistance as experimental treatment of metabolic syndrome.

Methods

Five groups were formed in the study. Fructose (20%) was administered with drinking water for 8 weeks to develop metabolic syndrome. For treatment, curcumin (100 mg/kg/day) and L. acidophilus (2 × 108 cfu/ml/day) were given individually or in combination for the last four weeks. At the end of the experiment; insulin, resistin, leptin, adipokines, apelin and nitric oxide levels were determined by ELISA test kits. Total cholesterol, triglyceride, glucose, albumin and total protein levels were determined by autoanalyzer.

Results

The levels of apelin, resistin, glucose, total cholesterol and triglyceride increased significantly (P < 0.05) in the fructose added to drinking water groups whereas curcumin and L. acidophilus probiotics given individually or together groups for treatment started to decrease and the nitric oxide level decreased significantly. Insulin resistance was found to be significantly higher in the group with metabolic syndrome and insulin resistance developed. In the curcumin and probiotics given group, it was determined that the insulin resistance score was lowered compared to the group only given fructose. The administration of L. acidophilus probiotic and curcumin in rats with metabolic syndrome caused by fructose improves hormone levels and reduces insulin resistance.

Conclusions

These results showed that the addition of dietary curcumin as an antioxidant and probiotic could provide a natural alternative for the treatment of metabolic syndrome induced by fructose.
Literature
1.
go back to reference Solak A, Tuncal P. Leptin, adiponectin, oxidized LDL levels and paraoxonase activity in Metabolic Syndrome. Turk J Clin Biochem. 2009;7(1):22–9. Solak A, Tuncal P. Leptin, adiponectin, oxidized LDL levels and paraoxonase activity in Metabolic Syndrome. Turk J Clin Biochem. 2009;7(1):22–9.
2.
go back to reference Deepa M, Farooq S, Datt M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRef Deepa M, Farooq S, Datt M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRef
3.
go back to reference Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008;7:27.CrossRef Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008;7:27.CrossRef
4.
go back to reference Rezaianzadeh A, Namayandeh SM, Sadr SM. National cholesterol education program adult treatment panel III versus international diabetic federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease? Int J Prev Med. 2012;3(8):552–8.PubMedPubMedCentral Rezaianzadeh A, Namayandeh SM, Sadr SM. National cholesterol education program adult treatment panel III versus international diabetic federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease? Int J Prev Med. 2012;3(8):552–8.PubMedPubMedCentral
5.
go back to reference Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci. 2008;114:275–88.CrossRef Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci. 2008;114:275–88.CrossRef
6.
go back to reference Huang H, Korivi M, Tsai CH, Yang JH, Tsai YC. Supplementation of Lactobacillus plantarum K68 and fruit-vegetable ferment along with high fat-fructose diet attenuates Metabolic Syndrome in rats with insulin resistance. Evid Based Complement Alternat Med. 2013;94:3020. Huang H, Korivi M, Tsai CH, Yang JH, Tsai YC. Supplementation of Lactobacillus plantarum K68 and fruit-vegetable ferment along with high fat-fructose diet attenuates Metabolic Syndrome in rats with insulin resistance. Evid Based Complement Alternat Med. 2013;94:3020.
7.
go back to reference FAO/WHO. Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada: 2002. FAO/WHO. Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada: 2002.
8.
go back to reference Özden A. Gastro-intestinal Sistem ve Probiyotik-Prebiyotik Sinbiyotik, Ankara Üniversitesi Tıp Fakültesi, Gastroenteroloji Bilim Dalı. Eylül: Ankara, Güncel Gastroenteroloji; 2005. 9/3. Özden A. Gastro-intestinal Sistem ve Probiyotik-Prebiyotik Sinbiyotik, Ankara Üniversitesi Tıp Fakültesi, Gastroenteroloji Bilim Dalı. Eylül: Ankara, Güncel Gastroenteroloji; 2005. 9/3.
9.
go back to reference Park DY, Ahn YT, Huh CS, McGregor RA, Choi MS. Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J Gastroenterol. 2013;19:274–83.CrossRef Park DY, Ahn YT, Huh CS, McGregor RA, Choi MS. Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J Gastroenterol. 2013;19:274–83.CrossRef
10.
go back to reference Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620–37.CrossRef Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620–37.CrossRef
11.
go back to reference Park YH, Kim JG, Shin YW, Kim SH, Whang KY. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J Microbiol Biotechnol. 2006;17(4):655–62. Park YH, Kim JG, Shin YW, Kim SH, Whang KY. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J Microbiol Biotechnol. 2006;17(4):655–62.
12.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glu cose tolerance and insulin sensitivity. Diabet Care. 2000;23:57–63.CrossRef Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glu cose tolerance and insulin sensitivity. Diabet Care. 2000;23:57–63.CrossRef
13.
go back to reference Dornas WC, Lima WG, Pedrosa ML, Silva ME. Health implications of high-fructose intake and current research. Adv Nutr. 2015;6:729–37.CrossRef Dornas WC, Lima WG, Pedrosa ML, Silva ME. Health implications of high-fructose intake and current research. Adv Nutr. 2015;6:729–37.CrossRef
14.
go back to reference Mohammadi S, Bardei LK, Hojati V, Ghorbani AG, Nabiuni M. Anti-inflammatory effects of curcumin on insulin resistance index, levels of interleukin-6, C-reactive protein, and liver histology in polycystic ovary syndrome-induced rats. Cell J. 2017;19(3):425–33.PubMedPubMedCentral Mohammadi S, Bardei LK, Hojati V, Ghorbani AG, Nabiuni M. Anti-inflammatory effects of curcumin on insulin resistance index, levels of interleukin-6, C-reactive protein, and liver histology in polycystic ovary syndrome-induced rats. Cell J. 2017;19(3):425–33.PubMedPubMedCentral
15.
go back to reference Panda V, Mistry K, Sudhamani S, Nandave M, Ojha SK. Amelioration of abnormalities associated with the Metabolic Syndrome by Spinacia oleracea consumption and aerobic exercise in rats. Oxid Med Cell Longev. 2017;1:1–15.CrossRef Panda V, Mistry K, Sudhamani S, Nandave M, Ojha SK. Amelioration of abnormalities associated with the Metabolic Syndrome by Spinacia oleracea consumption and aerobic exercise in rats. Oxid Med Cell Longev. 2017;1:1–15.CrossRef
16.
go back to reference Kelany ME, Hakami TM, Omar AH. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Can J Physiol Pharmacol. 2017;95(2):140–50.CrossRef Kelany ME, Hakami TM, Omar AH. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Can J Physiol Pharmacol. 2017;95(2):140–50.CrossRef
17.
go back to reference Yang YS, Su YF, Yang HW, Lee YH, Chou I, Ueng JI. KC. Lipid-lowering effects of curcumin in patients with Metabolic Syndrome: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2014;28:1770–7. Yang YS, Su YF, Yang HW, Lee YH, Chou I, Ueng JI. KC. Lipid-lowering effects of curcumin in patients with Metabolic Syndrome: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2014;28:1770–7.
18.
go back to reference Panahia Y, Khalilib N, Sadat Hosseinib M, Abbasinazaric M, Sahebkard A. Lipid-modifying effects of adjunctive therapy with curcuminoids piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med. 2014;22:851–7. Panahia Y, Khalilib N, Sadat Hosseinib M, Abbasinazaric M, Sahebkard A. Lipid-modifying effects of adjunctive therapy with curcuminoids piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med. 2014;22:851–7.
19.
go back to reference Festi D, Schiumerini R, Eusebi HL, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20(43):16079–94.CrossRef Festi D, Schiumerini R, Eusebi HL, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20(43):16079–94.CrossRef
20.
go back to reference Raucci R, Rusolo F, Sharma A, Colonna G, Castello G, Costantini S. Functional and structural features of adipokine family. Cytokine. 2013;61:1–14.CrossRef Raucci R, Rusolo F, Sharma A, Colonna G, Castello G, Costantini S. Functional and structural features of adipokine family. Cytokine. 2013;61:1–14.CrossRef
21.
go back to reference Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in theregulation of food intake and body weight in humans: a review. Obes Rev. 2007;8:21–34.CrossRef Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in theregulation of food intake and body weight in humans: a review. Obes Rev. 2007;8:21–34.CrossRef
22.
go back to reference Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537–56.CrossRef Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537–56.CrossRef
23.
go back to reference Naira S, Gagnona J, Pelletiera C, et al. Shrimp oil extracted from the shrimp processing waste reduces the development of insulin resistance and metabolic phenotypes in diet-induced obese rats. Appl Physiol Nutr Metab. 2017;42(8):841–9.CrossRef Naira S, Gagnona J, Pelletiera C, et al. Shrimp oil extracted from the shrimp processing waste reduces the development of insulin resistance and metabolic phenotypes in diet-induced obese rats. Appl Physiol Nutr Metab. 2017;42(8):841–9.CrossRef
24.
go back to reference Yamauchi T, Kamon J, Waki H, et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–6.CrossRef Yamauchi T, Kamon J, Waki H, et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–6.CrossRef
25.
go back to reference Jung UJ, Choi MS. Obesity and its metabolic complications: the role ofadipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.CrossRef Jung UJ, Choi MS. Obesity and its metabolic complications: the role ofadipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.CrossRef
26.
go back to reference Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–9.CrossRef Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–9.CrossRef
27.
go back to reference Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–8.CrossRef Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–8.CrossRef
28.
go back to reference Arita Y, Kihara S, Ouchi N. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83.CrossRef Arita Y, Kihara S, Ouchi N. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83.CrossRef
29.
go back to reference Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.CrossRef Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.CrossRef
30.
go back to reference Adamczak M, Wiecek A, Funahashi T, Chudek J, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72–5.CrossRef Adamczak M, Wiecek A, Funahashi T, Chudek J, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72–5.CrossRef
31.
go back to reference Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–8.CrossRef Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–8.CrossRef
32.
go back to reference Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the Metabolic Syndrome in children and adolescents. J Med. 2004;350:23. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the Metabolic Syndrome in children and adolescents. J Med. 2004;350:23.
33.
go back to reference Aslam M, Madhu SV. Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels. Endocrine. 2017;58:59–65.CrossRef Aslam M, Madhu SV. Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels. Endocrine. 2017;58:59–65.CrossRef
34.
go back to reference Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N, Sheng L, Shi Y, Zhang Y. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem. 2007;18:64–72.CrossRef Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N, Sheng L, Shi Y, Zhang Y. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem. 2007;18:64–72.CrossRef
35.
go back to reference Sakr HF. Modulation of metabolic and cardiac dysfunctions by swimming in overweight rats on a high cholesterol and fructose diet: possible role of adiponectin. J Physiol Pharmacol. 2013;64(2):231–40.PubMed Sakr HF. Modulation of metabolic and cardiac dysfunctions by swimming in overweight rats on a high cholesterol and fructose diet: possible role of adiponectin. J Physiol Pharmacol. 2013;64(2):231–40.PubMed
36.
go back to reference Heinonen MV, Laaksonen DE, Karhu T, Karhunen L, Laitinen T, Kainulainen S. Effects of diet-induced weight loss on plasma apelinand cytokine levels in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19:626–33.CrossRef Heinonen MV, Laaksonen DE, Karhu T, Karhunen L, Laitinen T, Kainulainen S. Effects of diet-induced weight loss on plasma apelinand cytokine levels in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19:626–33.CrossRef
37.
go back to reference Dray C, Sakar Y, Vinel C, Daviaud D, Masri B, Garrigues L. The intestinal glucose-apelin cycle controls carbohydate absorption in mice. Gastroenterol. 2013;144:771–80.CrossRef Dray C, Sakar Y, Vinel C, Daviaud D, Masri B, Garrigues L. The intestinal glucose-apelin cycle controls carbohydate absorption in mice. Gastroenterol. 2013;144:771–80.CrossRef
38.
go back to reference Yue P, Jin H, Marissa A, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, Tsao PS. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298:59–67.CrossRef Yue P, Jin H, Marissa A, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, Tsao PS. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298:59–67.CrossRef
39.
go back to reference Beltowski J. Apelin and visfatin: Unique “beneficial” adipokines upregulated in obesity? Med Sci Monit. 2006;12:112–9. Beltowski J. Apelin and visfatin: Unique “beneficial” adipokines upregulated in obesity? Med Sci Monit. 2006;12:112–9.
40.
go back to reference Han Y, Han HJ, Kim AH, Choi JY, Cho SJ, Park YB, Un JJ, Choi MS. D-Allulose supplementation normalized the body weight nd fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition. Mol Nutr Food Res. 2016;60:1695–706.CrossRef Han Y, Han HJ, Kim AH, Choi JY, Cho SJ, Park YB, Un JJ, Choi MS. D-Allulose supplementation normalized the body weight nd fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition. Mol Nutr Food Res. 2016;60:1695–706.CrossRef
41.
go back to reference Selvi NMK, Sridhar MG, Swaminathan RP, Sripradha R, Badhe B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm Biol. 2016;54(12):2857–63.CrossRef Selvi NMK, Sridhar MG, Swaminathan RP, Sripradha R, Badhe B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm Biol. 2016;54(12):2857–63.CrossRef
42.
go back to reference Jang EH, Park CS, Lee SK, Pie JE, Kang JH. Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation. Life Sci. 2007;80(7):609–17.CrossRef Jang EH, Park CS, Lee SK, Pie JE, Kang JH. Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation. Life Sci. 2007;80(7):609–17.CrossRef
Metadata
Title
The effects of curcumin and Lactobacillus acidophilus on certain hormones and insulin resistance in rats with metabolic syndrome
Authors
Fatma Semina Kapar
Gülay Ciftci
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00578-1

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.